Plegridy(TM) marketing applications accepted for review

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

Plegridy(TM) marketing applications accepted for review

Postby MSUK » Mon Jul 22, 2013 7:56 am

US and EU regulatory authorities accept Plegridy(TM) (peginterferon beta-1a) marketing applications for review

Biogen Idec announced that U.S. and EU regulatory authorities have accepted the marketing applications for the review of Plegridy(TM) (peginterferon beta-1a), the company's pegylated subcutaneous injectable candidate for relapsing forms of multiple sclerosis (MS). The U.S. Food and Drug Administration (FDA) has accepted Biogen Idec's Biologics License Application (BLA) for marketing approval of PLEGRIDY in the United States and granted the company a standard review timeline. The Marketing Authorisation Application (MAA) of Plegridy for review in the European Union was also validated by the European Medicines Agency...... Read More - http://www.ms-uk.org/index.cfm/PEGylatedinterferonbeta
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2142
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Return to General Discussion

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service

cron